Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Pliant Therapeutics, Inc.

Clinical trials sponsored by Pliant Therapeutics, Inc., explained in plain language.

Pliant Therapeutics, Inc. PLRX NASDAQ

A clinical-stage biopharmaceutical company developing treatments for fibrosis.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Completed 2 Terminated 1

Can a new pill slow lung scarring in IPF?

Disease control Terminated

This clinical trial is testing an investigational drug called bexotegrast (PLN-74809) in people with idiopathic pulmonary fibrosis (IPF), a disease that causes progressive lung scarring and breathing difficulties. The study will compare different doses of bexotegrast against a pl…

Phase: PHASE2 • Sponsor: Pliant Therapeutics, Inc. • Aim: Disease control

Last updated Aug 07, 2026 00:00 UTC